June 20, 2018 3:49 PM ET

Life Sciences Tools and Services

Company Overview of Gallus Biopharmaceuticals, LLC

Key Executives for Gallus Biopharmaceuticals, LLC

NameBoard RelationshipsTitleAge
Mark R. Bamforth 11 RelationshipsFounder, Chief Executive Officer, President and Director--
Steven H. Kasok No RelationshipsFounder and Chief Financial Officer--
Mark W. Bell No RelationshipsChief Manufacturing Officer--

Gallus Biopharmaceuticals, LLC Board Members*

NameBoard RelationshipsPrimary CompanyAge
Mark R. Bamforth 11 RelationshipsGallus Biopharmaceuticals, LLC--
Geoffrey F. Cox 111 RelationshipsVaxart, Inc.74
Walker L. Poole 13 RelationshipsRidgemont Equity Partners--
Jack J. Purcell 11 RelationshipsRidgemont Equity Partners--
David P. Lavins Jr., CFA 6 RelationshipsGallus Biopharmaceuticals, LLC--
View All Board Members

Gallus Biopharmaceuticals, LLC Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
Gallus Biopharmaceuticals, LLC CEO Compensation
Industry Average


Jean Philibert Joins 10x Genomics as Chief People Officer
June 14, 2018 12:00 PM ET
Metabolon, Inc. Announces Executive Changes
June 13, 2018 1:00 PM ET
Catalent Pharma Solutions Appoints Paul Hegwood as President of its Clinical Supply Services Business
June 13, 2018 12:00 AM ET
Shanghai ChemPartner Appoints Ming Liu as Vice President and the Head of Biology and Pharmacology
June 12, 2018 3:00 PM ET
Worldwide Clinical Trials, Inc. Appoints Nikola Strumberger as Vice President, Therapeutic Area Strategy Leads
June 11, 2018 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Gallus Biopharmaceuticals, LLC, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.